Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Milinkovic

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Expert Review of Anti-Infective Therapy|October 16, 2004
Nevirapine in the treatment of HIVAna Milinkovic, Esteban Martínez
Frontiers in Aging|October 2, 2023
Two vicious circles associated with the aging of the immune system in the development of severe forms of COVID-19Miodrag Vrbic, Ana Milinkovic
The Journal of Antimicrobial Chemotherapy|May 21, 2005
Current perspectives on HIV-associated lipodystrophy syndromeAna Milinkovic, Esteban Martinez
Journal of the International AIDS Society|November 14, 2014
Low clinical relevance of risky alcohol consumption in a selected group of high adherent HIV-infected patients attended in the United KingdomAlicia Gonzalez Baeza, Ana Milinkovic, Alejandro Arenas-Pinto
AIDS (London, England)|November 26, 2019
Reversible effect on lipids by switching from tenofovir disoproxil fumarate to tenofovir alafenamide and backAna Milinkovic, Florian Berger, Alejandro Arenas-Pinto, et al.
AIDS and Behavior|October 31, 2019
Risky Alcohol Consumption and Associated Health Behaviour Among HIV-Positive and HIV-Negative Patients in a UK Sexual Health and HIV Clinic: A Cross-Sectional Questionnaire StudyEmmi Suonpera, Rebecca Matthews, Ana Milinkovic, et al.
Expert Opinion on Pharmacotherapy|May 23, 2015
HIV integrase inhibitors: a new era in the treatment of HIVJose Luis Blanco, Gary Whitlock, Ana Milinkovic, et al.
Antiviral Therapy|October 7, 2016
An open-label, randomized study of the impact on insulin sensitivity, lipid profile and vascular inflammation by treatment with lopinavir/ritonavir or raltegravir in HIV-negative male volunteersPaul Randell, Akil Jackson, Ana Milinkovic, et al.
Antiviral Therapy|November 13, 2004
Management of dyslipidaemia in HIV-infected patients receiving antiretroviral therapyEsteban Martínez, Montserrat Tuset, Ana Milinkovic, et al.
International Journal of STD & AIDS|August 11, 2020
Multimodality assessment of sleep outcomes in people living with HIV performed using validated sleep questionnairesAna Milinkovic, Suveer Singh, Bryony Simmons, et al.
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Expert Review of Anti-Infective Therapy|October 16, 2004
Nevirapine in the treatment of HIVAna Milinkovic, Esteban Martínez
Frontiers in Aging|October 2, 2023
Two vicious circles associated with the aging of the immune system in the development of severe forms of COVID-19Miodrag Vrbic, Ana Milinkovic
The Journal of Antimicrobial Chemotherapy|May 21, 2005
Current perspectives on HIV-associated lipodystrophy syndromeAna Milinkovic, Esteban Martinez
Journal of the International AIDS Society|November 14, 2014
Low clinical relevance of risky alcohol consumption in a selected group of high adherent HIV-infected patients attended in the United KingdomAlicia Gonzalez Baeza, Ana Milinkovic, Alejandro Arenas-Pinto
AIDS (London, England)|November 26, 2019
Reversible effect on lipids by switching from tenofovir disoproxil fumarate to tenofovir alafenamide and backAna Milinkovic, Florian Berger, Alejandro Arenas-Pinto, et al.
AIDS and Behavior|October 31, 2019
Risky Alcohol Consumption and Associated Health Behaviour Among HIV-Positive and HIV-Negative Patients in a UK Sexual Health and HIV Clinic: A Cross-Sectional Questionnaire StudyEmmi Suonpera, Rebecca Matthews, Ana Milinkovic, et al.
Expert Opinion on Pharmacotherapy|May 23, 2015
HIV integrase inhibitors: a new era in the treatment of HIVJose Luis Blanco, Gary Whitlock, Ana Milinkovic, et al.
Antiviral Therapy|October 7, 2016
An open-label, randomized study of the impact on insulin sensitivity, lipid profile and vascular inflammation by treatment with lopinavir/ritonavir or raltegravir in HIV-negative male volunteersPaul Randell, Akil Jackson, Ana Milinkovic, et al.
Antiviral Therapy|November 13, 2004
Management of dyslipidaemia in HIV-infected patients receiving antiretroviral therapyEsteban Martínez, Montserrat Tuset, Ana Milinkovic, et al.
International Journal of STD & AIDS|August 11, 2020
Multimodality assessment of sleep outcomes in people living with HIV performed using validated sleep questionnairesAna Milinkovic, Suveer Singh, Bryony Simmons, et al.
Pageof 8